Fortrea Announces Date for Second Quarter 2024 Financial Results and Conference Call

Rhea-AI Summary

Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), has announced the date for its second quarter 2024 financial results release and conference call. The company will release its financial results before the market opens on Monday, August 12, 2024. A conference call is scheduled for 9:00 am ET on the same day to review the results and conduct a Q&A session.

Participants can register for the earnings call on the Fortrea Investor Relations website and are advised to join at least 10 minutes before the call starts. The call can also be accessed through an earnings webcast link. A replay of the live conference call will be available shortly after the event concludes and can be accessed on the events and presentations section of the Fortrea Investor Relations website.

DURHAM, N.C., July 17, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its second quarter 2024 financial results before the market opens on Monday, August 12, 2024. Fortrea will host a conference call at 9:00 am ET that day to review its financial results and conduct a question-and-answer session.

To participate in the earnings call, participants should register online at the Fortrea Investor Relations website. To avoid potential delays, please join at least 10 minutes prior to the start of the call. The conference call can also be accessed through the following earnings webcast link.

A replay of the live conference call will be available shortly after the conclusion of the event and accessible on the events and presentations section of the Fortrea Investor Relations website.

About Fortrea

Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com and follow us on LinkedIn and X (formerly Twitter).

Fortrea Contacts:

Hima Inguva (Investors) – 877-495-0816, hima.inguva@fortrea.com
Sue Zaranek (Media) – 919-943-5422, media@fortrea.com
Kate Dillon (Media) – 646-818-9115, kdillon@prosek.com

FAQ

When will Fortrea (FTRE) release its Q2 2024 financial results?

Fortrea (FTRE) will release its second quarter 2024 financial results before the market opens on Monday, August 12, 2024.

What time is Fortrea's (FTRE) Q2 2024 earnings conference call scheduled for?

Fortrea's (FTRE) Q2 2024 earnings conference call is scheduled for 9:00 am ET on Monday, August 12, 2024.

How can investors participate in Fortrea's (FTRE) Q2 2024 earnings call?

Investors can participate in Fortrea's (FTRE) Q2 2024 earnings call by registering online at the Fortrea Investor Relations website or accessing the call through the provided earnings webcast link.

Will there be a replay available for Fortrea's (FTRE) Q2 2024 earnings call?

Yes, a replay of Fortrea's (FTRE) Q2 2024 earnings call will be available shortly after the conclusion of the event on the events and presentations section of the Fortrea Investor Relations website.